Skip to main content
. 2023 Sep 13;12(9):1850–1861. doi: 10.21037/tlcr-23-331

Figure 5.

Figure 5

Kaplan-Meier curves in EGFR and ALK wild type patients treated with ICI monotherapy according to TTF-1 and PD-L1 expression status. (A) PFS in PD-L1 <1%; (B) PFS in PD-L1 1–49%; (C) PFS in PD-L1 ≥50%; (D) OS in PD-L1 <1%; (E) OS in PD-L1 1–49%; (F) OS in PD-L1 ≥50%. PD-L1, programmed death-ligand 1; TTF-1, thyroid transcription factor-1; PFS, progression-free survival; CI, confidence interval; HR, hazard ratio; OS, overall survival; NR, not reached; EGFR, epidermal growth factor receptor; ALK, anaplastic lymphoma kinase; ICI, immune checkpoint inhibitor.